Nifty Pharma Bleeds Red Over Looming Tariffs Comment
Shares of Indian pharmaceutical businesses, including Gland Pharma Ltd, Laurus Labs Ltd, Glenmark Pharmaceuticals Ltd, and Biocon Ltd, dropped as much as 8% on Monday,...
Tag : Biocon
Biocon Shares Surge 2% on Approval from USFDA for Blood Pressure Drug
Shares of Biocon Ltd were trading in the green and 2% higher on 24 March after the company’s subsidiary announced securing approval from the USFDA...
Biocon Shares Gain 2% as Subsidiary Launches Yesintek in US
Shares of Biocon, a pharmaceutical company, rose by as much as 2% on Tuesday, 25 February, after Biocon Biologics, a fully integrated global biosimilars company...
Biocon Shares Gain 4% as Malaysia Unit Gets Clearance from USFDA
Shares of Biocon were trading 4% higher on 13 January after the company’s subsidiary Biocon Biologics’ insulin factory in Malaysia got cleared by the US...
Biocon Shares Slump 4% as Bengaluru API Unit Gets VAI Tag
Shares of Biocon Ltd slumped 4% on Monday, 9 December, after the company’s Bengaluru Unit received an Establishment Inspection Report (EIR) with a Voluntary Action...
Biocon Subsidiary Secures USFDA Approval
Biocon on 31 August announced that their wholly-owned subsidiary, Biocon Pharma Ltd received US Food and Drug Administration (USFDA) for its Abbreviated New Drug Application...
Biocon Biologics and Janssen Settle to Launch Biosimilar Bmab 1200, Shares Trading Flat
Shares of Biocon Ltd. are trading flat after reaching a day’s high of Rs 364.95 on 29th August. This follows the company’s announcement that its...
Biocon Shares Gain 1% on Receiving Nod from UK Health Agency
Biocon shares were trading 1% higher on 15 November after Biocon Biologics, a subsidiary of the company, announced receiving marketing authorisation from the Medicines and...
Biocon Shares Fall 4% as Malaysia Unit Red Flagged by USFDA
Shares of Biocon tumbled 4% on 18 October after the company’s Malaysia unit was red-flagged by the USFDA (US Food and Drug Administration). The company...
Biocon Q1 Report; Net Profit Tumbles by 30%; Shares Plunge 3%
The biopharmaceutical company Biocon has released its financial results for the April-June quarter for the 2023-24 fiscal year. The company reported a 30% YoY decline...
